Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126693081 | 12669308 | 1 | I | 20160709 | 20160810 | 20160819 | 20160819 | EXP | FR-PFIZER INC-2016382588 | PFIZER | 56.00 | YR | F | Y | 0.00000 | 20160819 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126693081 | 12669308 | 1 | PS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY | Y | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||||
| 126693081 | 12669308 | 2 | SS | INSULIN | INSULIN NOS | 1 | UNK | Y | 0 | ||||||||||
| 126693081 | 12669308 | 3 | SS | NOVONORM | REPAGLINIDE | 1 | Oral | 2 MG (1 MG X2), 2X/DAY | Y | 0 | 2 | MG | TABLET | BID | |||||
| 126693081 | 12669308 | 4 | C | AMLOR | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, 2X/DAY | 0 | 5 | MG | CAPSULE | BID | ||||||
| 126693081 | 12669308 | 5 | C | HYPERIUM | RILMENIDINE PHOSPHATE | 1 | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | |||||||
| 126693081 | 12669308 | 6 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD | ||||||||
| 126693081 | 12669308 | 7 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | 0 | ||||||||||||
| 126693081 | 12669308 | 8 | C | LASILIX SPECIAL | FUROSEMIDE | 1 | Oral | 500 MG, 1X/DAY | 0 | 500 | MG | TABLET | QD | ||||||
| 126693081 | 12669308 | 9 | C | MOPRAL /00661201/ | OMEPRAZOLE SODIUM | 1 | 20 MG, 2X/DAY | 0 | 20 | MG | BID | ||||||||
| 126693081 | 12669308 | 10 | C | SPASFON | PHLOROGLUCINOL | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 126693081 | 12669308 | 11 | C | SPECIAFOLDINE | FOLIC ACID | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 126693081 | 12669308 | 12 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 0 | ||||||||||||
| 126693081 | 12669308 | 13 | C | ARANESP | DARBEPOETIN ALFA | 1 | 30 UG, WEEKLY | 0 | 30 | UG | /wk |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126693081 | 12669308 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126693081 | 12669308 | Blood potassium increased | |
| 126693081 | 12669308 | Confusional state | |
| 126693081 | 12669308 | Hyperglycaemia | |
| 126693081 | 12669308 | Hypoglycaemia | |
| 126693081 | 12669308 | Hypothermia | |
| 126693081 | 12669308 | Neck pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |